logo
welcome
ScienceDaily

ScienceDaily

Adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma

ScienceDaily
Summary
Nutrition label

79% Informative

An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute in collaboration with 10 major brain tumor centers around the country has reported initial results in the Journal of Clinical Oncology .

The trial, called INSIGhT, is still underway testing additional therapies.

None of the therapies tested so far improved overall survival of patients.

The study's other co-first authors were Eudocia Quant Lee from Dana-Farber and Isabel Arrillaga-Romany from Massachusetts General Hospital .

Rahman : "This trial is more streamlined, but it's also rigorous, which makes it more likely that it will produce more reliable answers".

VR Score

90

Informative language

97

Neutral language

37

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links